Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
buprenorphine (1 trial)
dexmedetomidine (precedex) (3 trials)
icodextrin (Extraneal) (1 trial)
ketorolac (acuvail) (2 trials)
levobupivacaine (chirocaine) (3 trials)
mepivacaine (carbocaine) (2 trials)
morphine (1 trial)
prilocaine (citanest) (1 trial)
ropivacaine (naropin) (4 trials)
benserazide (1 trial)
levodopa (larodopa) (1 trial)
mucuna pruriens (1 trial)
neridronic acid (1 trial)
Arthritis (Phase 4)
Hallux Valgus (Phase 4)
Osteoarthritis (Phase 2)
Osteoarthritis, Knee (Phase 2)
Parkinson Disease (Phase 2)
Trials (7 total)
Trial APIs (13 total)
